Han Biomedical (ROCO:6999) Marketable Securities: NT$80.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6999 Han Biomedical Inc ROCO:6999
32 GF Score
Price NT$28.00
! 1 Warning Sign
View Full Analysis

What is Han Biomedical Marketable Securities?

Han Biomedical ROCO:6999 -0.18% 32 Marketable Securities is NT$80.0 Mil as of Jun. 2026. GuruFocus rates ROCO:6999 with a GF Score™ of 32/100. The stock has 1 warning sign investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Han Biomedical's Marketable Securities for the quarter that ended in Jun. 2026 was NT$80.0 Mil.

Han Biomedical's annual Marketable Securities stayed the same from Dec. 2023 (NT$80.0 Mil) to Dec. 2024 (NT$80.0 Mil) and stayed the same from Dec. 2024 (NT$80.0 Mil) to Dec. 2025 (NT$80.0 Mil).

Han Biomedical  (ROCO:6999) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Han Biomedical Marketable Securities Related Terms

Han Biomedical Marketable Securities Historical Data

* Premium members only.

The historical data trend for Han Biomedical's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Han Biomedical Marketable Securities Chart

Han Biomedical Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
0.00 0.00 80.00 80.00 80.00

Han Biomedical Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only 80.00 80.00 80.00 80.00 80.00
ROCO:6999
32GF Score
Han Biomedical Inc ROCO:6999
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Han Biomedical Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of NT$80.0 Mil mean?
Han Biomedical (ROCO:6999) has a Marketable Securities of NT$80.0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Han Biomedical and its competitors.
Is Han Biomedical's Marketable Securities too high?
Han Biomedical's current Marketable Securities is NT$80.0 Mil. Overall, Han Biomedical has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Han Biomedical's Marketable Securities compare to VRTX and REGN?
Han Biomedical's Marketable Securities of NT$80.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Han Biomedical and its competitors. Han Biomedical's current Marketable Securities is NT$80.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Han Biomedical stock overvalued right now?
Han Biomedical (ROCO:6999) has a current Marketable Securities of NT$80.0 Mil. The current Marketable Securities is NT$80.0 Mil. Han Biomedical's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Han Biomedical (ROCO:6999), the current Marketable Securities is NT$80.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Han Biomedical Business Description

Address Xintai 5th Road, 15F-11, No.99, Sec.1, Xizhi District, New Taipei City, TWN
Han Biomedical Inc operates as a bio-material technology platform for the tissue repair market.
32GF Score

Get the complete analysis for ROCO:6999

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$28.00
Price